A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.
A new long-acting H.I.V. prevention drug, lenacapavir, has become available in Zambia. This medication offers protection through injections administered only twice a year, a significant advancement in H.I.V. prevention. However, its arrival coincides with a period of reduced funding for the country's health sector, primarily due to cuts in American aid.
The successful rollout of this innovative H.I.V. prevention method is crucial for public health in Zambia, especially given the challenges posed by a strained healthcare system.
📌 Kaynak
Bu özet NYT Science kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →